Treatment of Alopecia Areata with Squaric Acid Dibutylester
December 2014
in “
Clinics in dermatology
”
New to Alopecia Areata? There is a guide in the encyclopedia. Read the guide → Studysummary This review discusses squaric acid dibutylester's use, effects, and safety in treating alopecia areata, but reports no new clinical results.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
The document reviewed the use of squaric acid dibutylester (SADBE) as a treatment for alopecia areata (AA), an autoimmune condition causing nonscarring hair loss. SADBE, a topical sensitizer, was found to be effective in stimulating hair regrowth in AA patients, with success rates ranging from 29% to 87%. Despite the lack of randomized controlled trials, observational studies indicated a response rate of approximately 50% to 60%. Adverse effects included eczema, blistering, and lymph node swelling. Prognostic factors such as disease duration and extent of alopecia could predict treatment responsiveness. The document concluded that SADBE was a safe and effective treatment, though further controlled studies were needed.
